ENGENE THERAPEUTICS INC C/WTS 31/10/2028 (TO PUR COM) | 8-K: FY2026 Q2 Revenue: USD 0
enGene Therapeutics Rebrands as Company Nears Commercialization
ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A | 10-K: FY2025 Revenue: USD 0
ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A | 8-K: FY2025 Revenue: USD 0
ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A | 10-Q: FY2025 Q3 EPS: USD 0.57
ENGENE HOLDINGS INC C/WTS 31/10/2028 (TO PUR COM) CL A | 8-K: FY2025 Q3 EPS: USD 0.57